We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-3.29%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$58.8M
Cap. Flow
-$3.43M
Cap. Flow %
-0.33%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GRTS
Gritstone bio, Inc. Common Stock
GRTS
+$3.43M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$448M 42.88%
15,396,116
NRIX icon
2
Nurix Therapeutics
NRIX
$2.81B
$167M 16.04%
5,383,333
RVMD icon
3
Revolution Medicines
RVMD
$43.7B
$164M 15.74%
3,580,252
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.44B
$117M 11.19%
4,768,181
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$86.3M 8.26%
485,710
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$61.4M 5.89%
2,626,631
GRTS
7
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-869,493
Closed -$3.43M

Similar funds

Column Group's Q1 2021 Portfolio in Review

As of Q1 2021, Column Group held 7 positions worth $1.04B, down 5.3% from $1.1B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group's Q1 2021 filing shows 1 closed position. The largest sale was Gritstone bio, Inc. Common Stock, an estimated $3.43M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group fully exited Gritstone bio, Inc. Common Stock in Q1 2021, selling an estimated $3.43M.
  • Column Group's ten largest holdings make up 100% of its $1.04B portfolio in Q1 2021.
  • Column Group opened 0 new positions and closed 1 in Q1 2021.
  • Column Group's portfolio value fell 5.3% quarter-over-quarter to $1.04B.

Based on Column Group's 13F filing for Q1 2021, filed 17 May 2021.